Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC)

NCT00619541 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Infusional 5-Fluorouracil
DRUG: Sorafenib (Bay 43-9006)

Sponsor

Italian Trial in Medical Oncology